tradingkey.logo

Cytek Biosciences Inc

CTKB

3.775USD

+0.135+3.71%
交易中 美东报价延迟15分钟
481.69M总市值
亏损市盈率 TTM

Cytek Biosciences Inc

3.775

+0.135+3.71%
关于 Cytek Biosciences Inc 公司
Cytek Biosciences, Inc. 是一家细胞分析解决方案公司。该公司利用其全光谱分析 (FSP) 技术提供高分辨率、高含量和高灵敏度的细胞分析,从而改进细胞分析工具。其 FSP 平台包括其核心仪器 Cytek Aurora 和 Northern Lights 系统;其细胞分选器 Cytek Aurora CS;Cytek Orion 试剂混合物制备系统;Amnis 和 Guava 品牌下的流式细胞仪和成像产品;以及试剂、软件和服务,为客户提供全面而综合的解决方案。其 Cytek Aurora 和 Cytek Northern Lights 系统是流式细胞仪,可提供高分辨率、高含量和高灵敏度的细胞分析。其 Cytek Aurora CS 是一种细胞分选器,利用其 FSP 技术的检测和灵敏度功能,从 40 多种生物标志物中分离出从低到高复杂度面板的活细胞群。
公司简介
公司代码CTKB
公司名称Cytek Biosciences Inc
上市日期Jul 23, 2021
CEODr. Wenbin Jiang, Ph.D.
员工数量648
证券类型Ordinary Share
年结日Jul 23
公司地址47215 Lakeview Boulevard
城市FREMONT
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编94538
电话18779229835
网址https://cytekbio.com
公司代码CTKB
上市日期Jul 23, 2021
CEODr. Wenbin Jiang, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Ming Yan, Ph.D.
Dr. Ming Yan, Ph.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
6.04M
+0.17%
Dr. Wenbin Jiang, Ph.D.
Dr. Wenbin Jiang, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
5.26M
+0.70%
Ms. Valerie Barnett, J.D.
Ms. Valerie Barnett, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
83.67K
+14.04%
Dr. Philippe Busque, Ph.D.
Dr. Philippe Busque, Ph.D.
Senior Vice President, Global Sales and Services
Senior Vice President, Global Sales and Services
18.92K
+18.83%
Ms. Deborah J. Neff
Ms. Deborah J. Neff
Lead Independent Director
Lead Independent Director
15.71K
--
Dr. Vera Imper, Ph.D.
Dr. Vera Imper, Ph.D.
Independent Director
Independent Director
15.71K
--
Michael Holder
Michael Holder
Independent Director
Independent Director
8.00K
+22.22%
Mr. William (Bill) Mccombe
Mr. William (Bill) Mccombe
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jack T. Ball, Jr.
Mr. Jack T. Ball, Jr.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Ming Yan, Ph.D.
Dr. Ming Yan, Ph.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
6.04M
+0.17%
Dr. Wenbin Jiang, Ph.D.
Dr. Wenbin Jiang, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
5.26M
+0.70%
Ms. Valerie Barnett, J.D.
Ms. Valerie Barnett, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
83.67K
+14.04%
Dr. Philippe Busque, Ph.D.
Dr. Philippe Busque, Ph.D.
Senior Vice President, Global Sales and Services
Senior Vice President, Global Sales and Services
18.92K
+18.83%
Ms. Deborah J. Neff
Ms. Deborah J. Neff
Lead Independent Director
Lead Independent Director
15.71K
--
Dr. Vera Imper, Ph.D.
Dr. Vera Imper, Ph.D.
Independent Director
Independent Director
15.71K
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Biotechnology, pharmaceutical, distributor and CRO
24.32M
58.68%
Academia and government
17.13M
41.32%
地区USD
名称
营收
占比
United States
18.54M
44.71%
EMEA
11.57M
27.90%
APAC
8.89M
21.45%
Other
2.46M
5.95%
业务
地区
业务USD
名称
营收
占比
Biotechnology, pharmaceutical, distributor and CRO
24.32M
58.68%
Academia and government
17.13M
41.32%
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.03%
The Vanguard Group, Inc.
6.13%
Brown Capital Management, LLC
5.89%
HHLR Advisors, Ltd.
5.26%
Yan (Ming)
4.77%
Other
64.92%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.03%
The Vanguard Group, Inc.
6.13%
Brown Capital Management, LLC
5.89%
HHLR Advisors, Ltd.
5.26%
Yan (Ming)
4.77%
Other
64.92%
股东类型
持股股东
占比
Investment Advisor
32.16%
Investment Advisor/Hedge Fund
19.89%
Individual Investor
9.24%
Hedge Fund
3.64%
Pension Fund
2.67%
Research Firm
1.68%
Bank and Trust
0.36%
Venture Capital
0.13%
Family Office
0.05%
Other
30.18%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
323
88.14M
69.58%
-10.95M
2025Q1
332
90.47M
71.35%
-13.48M
2024Q4
323
90.06M
70.25%
-11.48M
2024Q3
303
87.47M
66.52%
-16.26M
2024Q2
288
88.67M
67.45%
-13.39M
2024Q1
284
98.75M
75.24%
-12.70M
2023Q4
276
96.90M
74.11%
-15.57M
2023Q3
266
97.16M
71.81%
-17.75M
2023Q2
259
98.92M
72.71%
-3.90M
2023Q1
228
90.71M
67.01%
-5.56M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
16.50M
13.03%
-335.36K
-1.99%
Mar 31, 2025
The Vanguard Group, Inc.
9.60M
7.58%
-2.09M
-17.92%
Mar 31, 2025
Brown Capital Management, LLC
7.46M
5.89%
-782.64K
-9.49%
Mar 31, 2025
HHLR Advisors, Ltd.
6.66M
5.26%
--
--
Mar 31, 2025
Yan (Ming)
6.04M
4.77%
+10.32K
+0.17%
May 19, 2025
Jiang (Wenbin)
5.26M
4.15%
+36.82K
+0.70%
May 19, 2025
State Street Global Advisors (US)
4.38M
3.46%
-128.20K
-2.84%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.85M
2.25%
+1.02M
+55.91%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.69M
2.12%
+47.59K
+1.80%
Mar 31, 2025
New York State Common Retirement Fund
2.09M
1.65%
--
--
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Invesco S&P SmallCap Health Care ETF
0.25%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
SPDR S&P 600 Small Cap Value ETF
0.06%
Avantis US Small Cap Equity ETF
0.05%
iShares S&P Small-Cap 600 Value ETF
0.05%
iShares Biotechnology ETF
0.04%
Proshares Ultra Smallcap 600
0.03%
SPDR Portfolio Small Cap ETF (SPSM)
0.03%
Fidelity Enhanced Small Cap ETF
0.03%
iShares ESG Select Screened S&P Small-Cap ETF
0.03%
查看更多
Invesco S&P SmallCap Health Care ETF
占比0.25%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.06%
SPDR S&P 600 Small Cap Value ETF
占比0.06%
Avantis US Small Cap Equity ETF
占比0.05%
iShares S&P Small-Cap 600 Value ETF
占比0.05%
iShares Biotechnology ETF
占比0.04%
Proshares Ultra Smallcap 600
占比0.03%
SPDR Portfolio Small Cap ETF (SPSM)
占比0.03%
Fidelity Enhanced Small Cap ETF
占比0.03%
iShares ESG Select Screened S&P Small-Cap ETF
占比0.03%
分红派息
近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
KeyAI